ats-13-04
ats-13-02
ats-13-04
ats-13-02

ATS-13® Activity Assay

What is your testing algorithm for patients suspected of having thrombotic thrombocytopenic purpura (TTP)?

ATS-13 Activity Assay provides protocols to quantitatively measure ADAMTS-13 protease activity and determine the presence of inhibitory antibodies to ADAMTS-13 in human plasma.

ADAMTS-13 is the protease that cleaves von Willebrand Factor. Significant decreases or an absence of ADAMTS-13 activity can lead to the formation of ultra-large vWF fragments and trigger intravascular platelet aggregation and microthrombosis, causing the signs and symptoms of thrombotic thrombocytopenic purpura, TTP.

Quick and Easy

  • Set up in less than 10 minutes
  • Pre-diluted calibrators
  • Results in under 45 minutes

Sensitive

  • Utilizes fluorescence resonance energy transfer (FRET) technology with less test variability
  • % Activity and % Inhibition derived from a fluorescent endpoint

Research Use Only (RUO). Not for use in diagnostic procedures.

Resource Library

PACKAGE INSERTS (PI/ IFU), SAFETY DATA SHEETS (SDS), CERTIFICATES of ANALYSIS, LOT SPECIFIC FILES, and more can be accessed on our customer center.

Our Certifications

Related Products

pipetting-lab-04

Factor VIII Antibody Screen

luminex-lab-07

PF4 Enhanced® and PF4 IgG Assay​

Upcoming Events,
Webinars & Workshops

Upcoming Event

Webinar Workshop: MIA FORA Case Study

When

December 13th 2023

Where

Experience Our Virtual Lab

Seeing Beyond Limits

  • Transfuse
  • Transplant
  • Transform a Life
Immucor

3130 Gateway Drive, P.O. Box 5625, Norcross, GA 30091-5625

Call 855.IMMUCOR (855.466.8267) or 770.441.2051